KEVIN BITTERMAN

Profile

First Name

: KEVIN

Middle Name

:

Last Name

: BITTERMAN

Related Companies
Titles
Company Name
Related People
DIRECTOR, EXECUTIVE OFFICER
PARASOL THERAPEUTICS INC
DAVID ARKOWITZ, STEVEN BRUGGER, ALAN CRANE, EDWARD KANIA, BRIAN J.G. PEREIRA, M.D., RAM SASISEKHARAN
DIRECTOR
TARIS BIOMEDICAL INC
DENNIS AUSIELLO, CHRISTINE BUNT, MICHAEL CIMA, ROBERT CRANE, SARMA DUDDY, MICHAEL GREELEY, ED KANIA, EDWARD KANIA, ROBERT LANGER, DIANE MARCOU, ERNIE MARIO, CARY PFEFFER, PURNANAND SARMA
DIRECTOR
BIOLEX THERAPEUTICS, INC.
W. THOMAS AMICK, DAVID CASTALDI, DAVID L. CASTALDI, DENNIS J. DOUGHERTY, KURT GRAVES, JEFF LEIDEN, JEFFREY LEIDEN, P. SHERRILL NEFF, LIZA PAGE NELSON, LIZA PAGE NELSON, DALE A. SANDER, DAVID SPENCER, JAN P. TUREK, KLAUS VEITINGER, GLEN WILLIAMS
DIRECTOR
FOLLICA, INC
CHRISTOPHER EHRLICH, WILLIAM JU, KIRK RAAB, DAPHNE ZOHAR
DIRECTOR, EXECUTIVE OFFICER
VISTERRA, INC.
DAVID ARKOWITZ, STEVEN BRUGGER, ALAN CRANE, EDWARD KANIA, BRIAN J.G. PEREIRA, M.D., RAM SASISEKHARAN
DIRECTOR
KALA PHARMACEUTICALS, INC.
TODD BAZEMORE, CHAIM BERGER, MARK S. BLUMENKRANZ, KIM BRAZZELL, HONGMING CHEN, YONATAN COLMAN, PETER COUROSSI, MARJAN FARID, ANDREA FRANZ, BERNARD GILLY, GREG GRUNBERG, GREGORY GRUNBERG, JUSTIN HANES, MARK IWICKI, DARIUS KHARABI, ANDREW I. KOVEN, ANDREW L. KOVEN, ROBERT LANGER, DAVID LAZAR, CHARLES MCDERMOTT, AVI MINKOWITZ, C. DANIEL MYERS, ROBERT PAULL, GREGORY D. PERRY, GUILLAUME PFEFER, KEVIN POJASEK, HILLEL POSEN, BRENDAN PURDY, MARY REUMUTH, HOWARD B. ROSEN, RAJEEV SHAH, ROBERT TEPPER, ERIC L. TRACHTENBERG, KAREN WAGNER, CHEN YU
DIRECTOR
GENOCEA BIOSCIENCES, INC.
GIRISH AAKALU, MICHAEL ALFIERI, KENNETH BATE, ALI BEHBAHANI, KATRINE BOSLEY, PAMELA CARROLL, LEON CHEN, WILLIAM CLARK, RONALD COOPER, THOMAS DAVIS, DIANTHA DUVALL, DALTON EINHORN, ROBERT FARRELL JR., ROBERT E. FARRELL JR., JESSICA FLECHTNER, JESSICA BAKER FLECHTNER, SIMEON GEORGE, PAUL GIANNASCA, SETH HETHERINGTON, MICHAEL HIGGINS, STEPHEN HOFFMAN, STEVE HOFFMAN, HOWARD MAYER, DEREK MEISNER, ROBERT PAULL, GISELA SCHWAB, GEORGE SIBER, NARINDER SINGH, RAVI VENKATARAMANI, ASISH XAVIER
DIRECTOR
NEURONETICS, INC.
PETER ANASTASIOU, MARK BAUSINGER, MARK R. BAUSINGER, LESLIE BOTTORFF, JAMES BREIDENSTEIN, STEPHEN CAMPE, MICHAEL DALE, MICHAEL D. DALE, MARK DEMITRACK, PETER DONATO, BRIAN FARLEY, MARY HAILEY, CASSIE HALLBERG, GREG HARPER, RON HUNT, WILFRED JAEGER, GIL KLIMAN, ROBERT KUHLING, STEVE MACKINNON, SUE MCMONIGLE, STANFORD MILLER, P. SHERILL NEFF, P. SHERRILL NEFF, SHERILL P. NEFF, ANTHONY PUI, LIAM RATCLIFFE, MARK RIEHL, DAN SACHS, MARK SAXTON, BRUCE J. SHOOK, CHRISTOPHER THATCHER, JUDY WAYS, NORMAN WELDON
DIRECTOR
DIRECT VET MARKETING, INC.
BETSY ATKINS, PAUL BERGKAMP, EDWARD CAHILL, SEAN CARNEY, YUMIN CHOI, PHILIP FERNEAU, PHILIP J. FERNEAU, SARA KIM, SARAH KIM, TERRENCE MCGUIRE, EDWARD MCNAMARA, KERRY MUSE, RAVI SACHDEV, RAVI SADCHEV, BENJAMIN SHAW, BENJAMIN J. SHAW, DAVID SHAW, DAVID E. SHAW
DIRECTOR
EDITAS MEDICINE, INC.
ALEXIS BORISY, KATRINE BOSLEY, DOUGLAS COLE, ALEXANDRA GLUCKSMANN, ANDREW HACK, VIC MYER, BORIS NIKOLIC
DIRECTOR
MORPHIC HOLDING, LLC
NORBERT BISCHOFBERGER, GUSTAV CHRISTENSEN, BARBARA DALTON, WILLIAM DEVAUL, MARTIN EDWARDS, RAMY FARID, ROBERT FARRELL, ROBERT E. FARRELL, VIKAS GOYAL, SUSANNAH GRAY, NILESH KUMAR, ALEXEY A. LUGOVSKOY, NISHA NANDA, AMIR NASHAT, BRUCE ROGERS, MARC SCHEGERIN, JOSEPH P. SLATTERY, TIMOTHY SPRINGER, TIMOTHY A. SPRINGER, OTELLO STAMPACCHIA, PRAVEEN P. TIPIRNENI, PRAVEEN TIPRIRNENI
EXECUTIVE OFFICER
ATLAS VENTURE FUND XI, L.P.
N/A ATLAS VENTURE ASSOCIATES XI, L.P., N/A ATLAS VENTURE ASSOCIATES XI, LLC, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, DAVID GRAYZEL, JASON RHODES
DIRECTOR
NAVITOR PHARMACEUTICALS, INC.
BARRY BURGDORF, ALAN CRANE, JOHN CREECY, RAJEEV DADOO, JEAN-FRANCOIS FORMELA, PAUL FRIEDMAN, PAUL FRIEDMAN, M.D., BRIAN GALLAGHER, BRIAN GALLAGHER, PH.D., DAVID GOLDFARB, THOMAS HUGHES, RICHARD LUNDBERG, RICK LUNDBERG, DAVID MADDEN, MARIAN NAKADA, MARIAN NAKADA, PH.D., VINZENZ PLOERER, GEORG VLASUK, GEORGE VLASUK, GEORGE P. VLASUK
DIRECTOR
AKERO THERAPEUTICS, INC.
ANDREW CHENG, MARK IWICKI, AARON KANTOFF, AARON ROYSTON, GRAHAM WALMSLEY, JONATHAN YOUNG
EXECUTIVE OFFICER
ATLAS VENTURE OPPORTUNITY FUND I, L.P.
N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P., N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, DAVID GRAYZEL, JASON RHODES
EXECUTIVE OFFICER
ATLAS VENTURE FUND XII, L.P.
N/A ATLAS VENTURE ASSOCIATES XII, L.P., N/A ATLAS VENTURE ASSOCIATES XII, LLC, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, MICHAEL GLADSTONE, DAVID GRAYZEL, JASON RHODES
DIRECTOR
KINASET THERAPEUTICS, INC.
JAMIL BEG, ROBERT CLARKE, ROGER HEERMAN, TOM KING, FRAZER MORGAN, BRAM VANPARYS
EXECUTIVE OFFICER
ATLAS VENTURE OPPORTUNITY FUND II, L.P.
N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY II, L.P., N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY II, LLC, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, MICHAEL GLADSTONE, DAVID GRAYZEL, JASON RHODES
EXECUTIVE OFFICER
ATLAS VENTURE FUND XIII, L.P.
N/A ATLAS VENTURE ASSOCIATES XIII, L.P., N/A ATLAS VENTURE ASSOCIATES XIII, LLC, BRUCE BOOTH, JEAN-FRANCOIS FORMELA, MICHAEL GLADSTONE, DAVID GRAYZEL, JASON RHODES
EXECUTIVE OFFICER, DIRECTOR
JUDO BIO INC.
SAM BJORK, OMMER CHOHAN, ROBERT GAFFEY, JAMES JEFFREY GOATER, GEORGE GOLUMBESKI, CHELSEA PLACE JOHNSON, ANKIT MAHADEVIA, HUI TIAN
DIRECTOR
CHROMA MEDICINE, INC.
THOMAS CAHILL, BIHUA CHEN, GEORGE GOLUMBESKI, BRETT KAPLAN, MICHAEL KELLY, JEFF MARRAZZO, VIC MYER, PAOLA POZZI, CATHERINE STEHMAN-BREEN
DIRECTOR
REMIX THERAPEUTICS, INC.
SCOTT BILLER, ROBERT GAGNON, JEFF GOATER, MATTHEW PATTERSON, MICHAEL ROME, PETER SMITH, HEATHER WASSERMAN
DIRECTOR
GRO BIOSCIENCES INC.
DAN BECKER, BRUCE BEUTEL, RAKHSHITA DHAR, MING FANG, CHRISTOPHER GREGG, TRACEY LODIE, DAINEL MANDELL, DANIEL MANDELL, DANIEL J MANDELL, GEOFFREY SMITH
EXECUTIVE OFFICER
ATLAS VENTURE FUND XIV, L.P.
N/A ATLAS VENTURE ASSOCIATES XIV, L.P., N/A ATLAS VENTURE ASSOCIATES XIV, LLC, BRUCE BOOTH, MICHAEL GLADSTONE, DAVID GRAYZEL, JASON RHODES
DIRECTOR
RENASANT BIO, INC.
EVAN CAPLAN, EMILY CONLEY, ANNA FRENCH, THOMAS GUSTAFSON, NATALIE HOLLES, JUNE LEE, CHARLOTTE MCKEE, DEBORAH PALESTRANT
EXECUTIVE OFFICER
ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY III, L.P., N/A ATLAS VENTURE ASSOCIATES OPPORTUNITY III, LLC, BRUCE BOOTH, MICHAEL GLADSTONE, JASON RHODES
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-04
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2025-08-26 
2025-07-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-15 
2025-07-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-06-03 
2024-12-05
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2024-12-04 
2024-08-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-31 
2024-07-25
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-18 
2024-06-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-05-17 
2024-01-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-12-22 
2023-11-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-04 
2023-09-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-02-08 
2023-07-17
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-05 
2023-03-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-02-08 
2022-11-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-04 
2022-07-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-05 
2022-03-03
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-03-02 
2021-10-01
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2021-09-30 
2020-08-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-31 
2020-06-04
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2020-05-20 
2020-05-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-21 
2019-01-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-12-17 
2019-01-02
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2018-12-07 
2018-12-18
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-10 
2018-03-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-02 
2017-06-30
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2017-06-28 
2016-07-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-29 
2016-04-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-04-06 
2015-08-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-17 
2015-08-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-04 
2015-07-17
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-02 
2015-07-16
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-02 
2015-05-07
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-24 
2015-03-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-10 
2014-12-03
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2014-11-21 
2014-04-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-16 
2013-12-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-14 
2013-10-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2013-09-30 
2013-07-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-28 
2013-06-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-04 
2013-04-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-06 
2013-04-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-18 
2013-02-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-14 
2013-01-03
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2012-12-20 
2012-11-19
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-14 
2012-10-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-28 
2012-05-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-14 
2012-03-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-29 
2011-06-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-05-27 
2011-05-23
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-13 
2011-04-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-06 
2011-01-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-17 
2010-11-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-10-26 
2010-11-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2010-10-25 
2010-09-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-09-03 
2010-09-10
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-21 
2010-07-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2010-07-21 
2010-06-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-21 
2010-02-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2010-02-11 
2009-12-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-04 
2009-12-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-11-30